Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15002134094 |
| E-mail: | marketing@targetmol.cn |
| QQ: | 2881954871 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| DDD01035881 | C14H14BrNO4S2 | 1396858-56-2 | Details |
| AS-1940477 hydrobromide | C24H23BrFN5O2 | 1404189-10-1 | Details |
| CM304 | C18H26ClFN2OS | 1417742-48-3 | Details |
| C3001a | C21H20N2O3S | 1374325-56-0 | Details |
| BZX2 | C17H13NO6 | 1349070-58-1 | Details |
| TP-S1-68 | C15H9ClN4S | 120187-04-4 | Details |
| R995045 | C16H15N4O3S | 1285536-79-9 | Details |
| Eleven-Nineteen-Leukemia Protein IN-3 | C28H27N5O2 | 2894121-83-4 | Details |
| 5-Iminodaunorubicin hydrochloride | C27H31ClN2O9 | 67324-99-6 | Details |
| ZINC32540717 | C23H26N4O3 | 1010869-76-7 | Details |
| ST101036 | C18H21F3N4 | 1018143-39-9 | Details |
| 3-Chlorogentisyl alcohol | C7H7ClO3 | 32744-80-2 | Details |
| Antileishmanial agent-13 | C17H10BrClN4O | 853725-86-7 | Details |
| RORγt inverse agonist 26 | C27H21F7N2O5S | 2738333-10-1 | Details |
| KRAS G12C inhibitor 20 | C33H37ClFN7O3 | 2640858-10-0 | Details |
| Antibacterial agent 64 | C29H20ClN3O6S2 | 618865-52-4 | Details |
| KRAS G12C inhibitor 32 | C29H30Cl3FN6O3 | 2756739-00-9 | Details |
| KRAS G12C inhibitor 39 | C37H43N9O2 | 2326522-16-9 | Details |
| KRAS G12C inhibitor 45 | C32H33F2N5O5S | 2670380-74-0 | Details |
| KRAS G12C inhibitor 37 | C35H39F3N8O2 | 2241720-04-5 | Details |
| KRAS G12C inhibitor 35 | C31H27ClF2N6O3 | 2650550-87-9 | Details |
| KRAS G12C inhibitor 41 | C36H37ClFN9O2 | 2660014-65-1 | Details |
| Enpp/Carbonic?anhydrase-IN-2 | C23H24FNO4S | 2883495-39-2 | Details |
| Tubulin polymerization-IN-40 | C24H22FNO5 | 2921670-94-0 | Details |
| 6-trans-12-epi-Leukotriene B4 | C20H32O4 | 71548-19-1 | Details |
| Difluorocyclooctyne-CH2-COOH | C10H12F2O2 | 1047997-31-8 | Details |
| NK1 receptor antagonist 2 | C31H35F7N4O2 | 579475-17-5 | Details |
| Anti-inflammatory agent 33 | C22H15N3O5S | 2816993-09-4 | Details |
| P2X7 receptor antagonist-3 | C17H12ClF3N6O | 1627900-92-8 | Details |
| P-CAB agent 2 hydrochloride | C22H26ClFN2O4S | 2209911-80-6 | Details |
| Antiproliferative agent-20 | C23H18N2O6 | 1344715-94-1 | Details |
| Eleven-Nineteen-Leukemia Protein IN-1 | C27H33N7O2 | 2894121-68-5 | Details |
| Mitochondria degrader-1 | C33H49ClFN7O8S | 2241669-05-4 | Details |
| Ladostigil hydrochloride | C16H21ClN2O2 | 209394-18-3 | Details |
| LC kinetic stabilizer-1 | C27H31N5O3 | 2495750-19-9 | Details |
| Metallo-β-lactamase-IN-9 | C13H12N6O3S | 1802363-75-2 | Details |
| α-Synuclein inhibitor 8 | C24H20N2O6 | 2883627-64-1 | Details |
| Antituberculosis agent-8 | C25H19F3N2O3 | 2874263-74-6 | Details |
| CB-892 | C15H14N2O4 | 1032336-22-3 | Details |
| Hsp90-IN-17 hydrochloride | C21H21ClN4O7 | 1253584-63-2 | Details |
| DSP-1053 benzenesulfonate | C32H38BrNO7S | 1176326-78-5 | Details |
| BRM/BRG1 ATP Inhibitor-3 | C26H25N5O2S2 | 2368901-31-7 | Details |
| Cathepsin K inhibitor 3 | C30H31FN4O4S | 1694638-70-4 | Details |
| MRS2768 tetrasodium salt | 2567869-47-8 | Details |
| Mtb-cyt-bd oxidase-IN-6 | C20H27NO | 1246461-10-8 | Details |
| Antibacterial agent 124 | C16H17ClFN3O2 | 2304448-00-6 | Details |
| (+)-Dihydrocalanolide A | C22H28O5 | 183904-53-2 | Details |
| Tilpisertib fosmecarbil | C35H36ClN8O7P | 2567459-64-5 | Details |
| LC kinetic stabilizer-2 | C28H31N3O3 | 2495750-20-2 | Details |
| ATM-3507 trihydrochloride (1861449-70-8 free base) | C37H47ClFN5O2 | 2438679-30-0 | Details |
| Velagliflozin proline hydrate | C28H34N2O7 | 1661838-94-3 | Details |
| Phosphoglycolohydroxamic acid | C2H6NO6P | 51528-59-7 | Details |
| Loxoprofenol-SRS tromethamine | C19H31NO6 | 2582872-01-1 | Details |
| (D-Met2,Pro5)-Enkephalinamide | C30H40N6O6S | 63307-63-1 | Details |
| Topoisomerase IV inhibitor 1 | C34H32FN7O6S | 2883403-42-5 | Details |
| Topoisomerase II inhibitor 7 | C32H28BrN5O5S | 2697171-03-0 | Details |
| Topoisomerase IV inhibitor 2 | C33H30FN7O6S | 2883403-36-7 | Details |
| VU0621623 | C20H21F2N5O3S | 1115899-15-4 | Details |
| ML-077 | C17H16N4OS2 | 1135304-61-8 | Details |
| PUN-96956 | C21H33ClN2 | 1144496-95-6 | Details |
| CPD7 HCl | C20H20ClNO3 | 1158740-21-6 | Details |
| ID110460002 | C20H25FN4O | 1172882-21-1 | Details |
| Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate | C10H16N5NaO11P2 | 9652-27-6 | Details |
| KYN-101 | C22H19FN6 | 2247950-73-6 | Details |
| Eleven-Nineteen-Leukemia Protein IN-2 | C22H23N5O2 | 2894121-78-7 | Details |
| D,L-erythro-PDMP hydrochloride | C23H39ClN2O3 | 80943-40-4 | Details |
| Glucocorticoid receptor modulator 1 | C24H23ClN2O4S | 2868357-11-1 | Details |
| ADRA1D receptor antagonist 1 free base | C15H13ClN4O | 1191908-24-3 | Details |
| Atorvastatin hemicalcium trihydrate | C33H39CaFN2O6 | 344920-08-7 | Details |
| Carbonic anhydrase inhibitor 12 | C27H22BrN5O5S2 | 2883451-38-3 | Details |
| Antituberculosis agent-6 | C27H20F2N2O3 | 2874263-72-4 | Details |
| DYRKs-IN-1 hydrochloride | C30H31Cl2N7O4 | 1386980-55-7 | Details |
| BRM/BRG1 ATP Inhibitor-4 | C25H32N6O3S | 2422030-94-0 | Details |
| Antiarrhythmic agent-1 | C25H27N3O4S | 136081-07-7 | Details |
| S1P5 receptor agonist-1 | C20H24F3NO3 | 2373330-78-8 | Details |
| Cyclic-di-GMP diammonium | C20H27N11O14P2 | 609343-82-0 | Details |
| (R,R)-Reboxetine mesylate | C20H27NO6S | 105017-39-8 | Details |
| Antiproliferative agent-17 | C26H28N2OS | 2882206-08-6 | Details |
| PF-06815345 hydrochloride | C27H30Cl2FN9O4 | 2334434-49-8 | Details |
| Larotinib mesylate hydrate | C25H30ClFN4O7S | 2097129-93-4 | Details |
| CypD-IN-29 | C26H20FN5O2S | 1115335-95-9 | Details |
| COR167 | C28H38N2O2 | 1048038-90-9 | Details |
| N 0840 | C11H15N5 | 109292-91-3 | Details |
| ZINC09410451 | C24H27ClN4O3 | 1093065-66-7 | Details |
| E09241 | C11H9ClN2O2 | 1043110-13-9 | Details |
| 673-A | C15H13NO | 109437-62-9 | Details |
| MAO-B ligand-1 | C19H19N5O4S | 1010879-39-6 | Details |
| Lagociclovir valactate | C18H25FN6O6 | 1001670-19-4 | Details |
| Asterriquinol D dimethyl ether | C26H24N2O4 | 287117-66-2 | Details |
| Menin-MLL inhibitor 26 | C27H29F3N6O3S | 2440018-29-9 | Details |
| KRAS G12D inhibitor 10 | C33H41ClN8O2 | 2648551-54-4 | Details |
| Antibacterial agent 19 | C16H16F2N2O4 | 79660-59-6 | Details |
| KRAS G12C inhibitor 40 | C34H36ClFN10O2 | 2660014-14-0 | Details |
| Cap-dependent endonuclease-IN-7 | C36H28FN3O7S | 2485715-97-5 | Details |
| (-)-15-Deoxyspergualin | 89149-10-0 | Details |
| β2AR/M-receptor agonist-2 | C36H49ClN4O7S | 1017857-38-3 | Details |
| PI3K/Akt/CREB activator 1 | C19H15F4NO3 | 2708177-73-3 | Details |
| Teslexivir hydrochloride | C35H37BrClN3O4 | 1075281-70-7 | Details |
| SRT 1720 dihydrochloride | C25H24ClN7OS | 2468639-77-0 | Details |
| 3β-Hydroxy-hop-22(29)-ene | C30H50O | 58801-23-3 | Details |
| Product Total： Product Page： | ||||
| 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 | ||||